Denali Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.9M | 202k | 14.52 |
| 2025-06-30 | $3.0M | 213k | 13.99 |
| 2025-03-31 | $2.6M | 190k | 13.59 |
| 2024-12-31 | $3.9M | 190k | 20.38 |
| 2024-09-30 | $5.5M | 190k | 29.13 |
| 2024-06-30 | $4.5M | 195k | 23.22 |
| 2024-03-31 | $3.5M | 172k | 20.52 |
| 2023-12-31 | $3.6M | 167k | 21.46 |
| 2023-09-30 | $3.5M | 169k | 20.63 |
| 2023-06-30 | $4.8M | 162k | 29.51 |
| 2023-03-31 | $3.4M | 146k | 23.04 |
| 2022-12-31 | $4.0M | 143k | 27.81 |
| 2022-09-30 | $3.9M | 128k | 30.69 |
| 2022-06-30 | $3.5M | 118k | 29.43 |
| 2022-03-31 | $3.1M | 97k | 32.17 |
| 2021-12-31 | $4.3M | 97k | 44.60 |
| 2021-09-30 | $4.9M | 97k | 50.45 |
| 2021-06-30 | $7.4M | 95k | 78.44 |
| 2021-03-31 | $4.1M | 72k | 57.10 |
| 2020-12-31 | $6.7M | 80k | 83.76 |
| 2020-09-30 | $2.8M | 79k | 35.83 |
| 2020-06-30 | $2.2M | 91k | 24.18 |
| 2020-03-31 | $1.2M | 66k | 17.50 |
| 2019-12-31 | $1.1M | 64k | 17.41 |
| 2019-09-30 | $961k | 63k | 15.32 |
| 2019-06-30 | $1.3M | 63k | 20.76 |
| 2019-03-31 | $1.4M | 60k | 23.21 |
| 2018-12-31 | $1.3M | 61k | 20.66 |
| 2018-09-30 | $829k | 38k | 21.74 |
| 2018-06-30 | $247k | 16k | 15.24 |
| 2018-03-31 | $274k | 14k | 19.71 |